Filing Details
- Accession Number:
- 0001225208-11-016062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-07 17:25:32
- Reporting Period:
- 2011-04-15
- Filing Date:
- 2011-06-07
- Accepted Time:
- 2011-06-07 17:25:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 810509 | Neoprobe Corp | NEOP | Surgical & Medical Instruments & Apparatus (3841) | 311080091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1195757 | C David Bupp | 425 Metro Place North Suite 300 Dublin OH 43017 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-15 | 300,000 | $0.00 | 2,543,328 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2011-06-03 | 234,000 | $4.52 | 2,613,328 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 129,056 | Indirect | By 401(k) |
| Common Stock | 213,746 | Indirect | By Spouse |
Footnotes
- The sales in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Bupp on June 1, 2011.
- Price represents a weighted average of the sale price. Shares were sold at prices ranging from $4.37 to $4.79. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.
Billionaire Hedge Funds
